Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine.
Coléon S, Wiedemann A, Surénaud M, Lacabaratz C, Hue S, Prague M, Cervantes-Gonzalez M, Wang Z, Ellis J, Sansoni A, Pierini C, Bardin Q, Fabregue M, Sharkaoui S, Hoest P, Dupaty L, Picard F, El Hajj M, Centlivre M, Ghosn J; French COVID Cohort Study Group; Thiébaut R, Cardinaud S, Malissen B, Zurawski G, Zarubica A, Zurawski SM, Godot V, Lévy Y.
Coléon S, et al. Among authors: prague m.
EBioMedicine. 2022 Jun;80:104062. doi: 10.1016/j.ebiom.2022.104062. Epub 2022 May 17.
EBioMedicine. 2022.
PMID: 35594660
Free PMC article.